GLUENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Monte Rosa Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.66+0.92 (+9.45%)
Close on Oct 19, 2026
- Market cap
- $1.08B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Monte Rosa Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 1, 2026 | Oct 1, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2026 | Jun 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2026 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 25, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2025 | Mar 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 10, 2025 | Jan 10, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 13, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 5, 2024 | Dec 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 25, 2024 | Oct 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2024 | Jun 12, 2024 | SEC EDGAR |
| Current report | 8-K | May 28, 2024 | May 30, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |